Treatment of Acute Ischemic StroKe With Intravenous UroKinase Real-world Research: a Multicenter, Prospective Study

Conditions: Acute Ischemic Stroke Interventions: Drug: Urokinase; Drug: Alteplase Sponsors: The First Affiliated Hospital of Zhengzhou University; Techpool Bio-Pharma Co., Ltd. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials